1126432-04-9 Usage
General Description
"(9aR)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride" is a chemical compound. It is part of the oxazine family, which is a group of heterocyclic compounds, compounds that contain a ring structure made up of at least two different elements. Like many of these compounds, it may have potential in pharmaceutical or other applications, because many of these molecules have exhibited significant biological activity. However, detailed information on this specific compound, such as its applications, risks, safety measures, and physical and chemical properties, is not readily available and may require further scientific research and investigation.
Check Digit Verification of cas no
The CAS Registry Mumber 1126432-04-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,2,6,4,3 and 2 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 1126432-04:
(9*1)+(8*1)+(7*2)+(6*6)+(5*4)+(4*3)+(3*2)+(2*0)+(1*4)=109
109 % 10 = 9
So 1126432-04-9 is a valid CAS Registry Number.
1126432-04-9Relevant articles and documents
PEPTIDE DEFORMYLASE INHIBITORS
-
, (2013/06/27)
The present invention relates to {2-(alkyl)-3-[2-(5-fluoro-4-pyrimidinyl)hydrazino]-3- oxopropyl}hydroxyformamide compounds of Formula (I): or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, processes for making and use of such compounds in the inhibition of bacterial peptide deformylase (PDF) activity and in treatment methods for bacterial infections
THIAZOLE AND OXAZOLE KINASE INHIBITORS
-
Page/Page column 209, (2009/04/25)
The present invention provides thiazole and oxazole compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
Imidazopyridine Kinase Inhibitors
-
Page/Page column 95, (2009/01/20)
The present invention provides imidazopyridine compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.
